32.28
-0.36
(-1.10%)
At close: April 15 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
4,736.73
4,736.73
6,273.67
7,617.77
1,381.36
Operating Income
-4,736.73
-4,736.73
-6,273.67
-7,617.77
-1,381.36
Other Income Expense
373.51
373.51
211.34
23.22
34.62
Pretax Income
-4,363.22
-4,363.22
-6,062.33
-7,594.56
-1,346.75
Net Income Common Stockholders
-4,301.84
-4,301.84
-5,871.13
-7,445.94
-1,346.75
Diluted NI Available to Com Stockholders
-4,301.84
-4,301.84
-5,871.13
-7,445.94
-1,346.75
Basic EPS
-0.33
--
-0.45
-0.58
-0.11
Diluted EPS
-0.33
--
-0.45
-0.58
-0.11
Basic Average Shares
13,012.87
--
13,012.87
12,805.71
12,642.11
Diluted Average Shares
13,012.87
--
13,012.87
12,805.71
12,642.11
Total Operating Income as Reported
-4,736.73
-4,736.73
-6,273.67
-7,617.77
-1,381.36
Total Expenses
4,736.73
4,736.73
6,273.67
7,617.77
1,381.36
Net Income from Continuing & Discontinued Operation
-4,301.84
-4,301.84
-5,871.13
-7,445.94
-1,346.75
Normalized Income
-4,301.84
-4,301.84
-5,871.13
-7,445.94
-1,346.75
EBIT
-4,736.73
-4,736.73
-6,273.67
-7,617.77
-1,381.36
EBITDA
-3,991.14
-3,991.14
-5,503.98
-7,013.37
-1,354.91
Reconciled Depreciation
745.59
745.59
769.69
604.40
26.46
Net Income from Continuing Operation Net Minority Interest
-4,301.84
-4,301.84
-5,871.13
-7,445.94
-1,346.75
Normalized EBITDA
-3,991.14
-3,991.14
-5,503.98
-7,013.37
-1,354.91
6/30/2021 - 7/16/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PRFX PainReform Ltd.
2.0300
-1.93%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.2610
-14.43%
QNTM Quantum BioPharma Ltd.
6.30
-6.25%
IXHL Incannex Healthcare Inc.
0.6100
-7.29%
UPC Universe Pharmaceuticals INC
3.3100
-1.49%
SBFM Sunshine Biopharma, Inc.
1.2800
-2.29%
CPHI China Pharma Holdings, Inc.
1.4700
+5.00%
YCBD cbdMD, Inc.
0.2240
-6.67%
SXTC China SXT Pharmaceuticals, Inc.
1.7000
-32.00%
PCRX Pacira BioSciences, Inc.
24.88
-0.36%